Target Audience:
Male or Female subjects ages 11 to 17 years of age.
Payment:
Up to $250 for time and travel.
Adolescent patients will receive the HPV vaccine or placebo and a meningococcal vaccine. If patients receive the placebo HPV vaccine, they will have the opportunity to receive the Gardisil vaccine at study end.
Study includes 5 office visits with 3 vaccinations and 2 blood draws. Visits are spread over a 14 month period.
Sign Up »
( via Clinical Conductor )